SSCRIMED
Healthcare buyerUnderstand SCRIMED quicklyDemo, pilot, or pricing ownerConvert demo interest into a priced pilot pathInvestor, strategic partner, or faith-based clinic sponsorUnderstand SCRIMED's investable and sellable value safely
Demo Center

CarePath AI · executable-demo

CarePath Access Operations Demo

Demonstrate how a fragmented high-risk follow-up queue becomes a reviewable operational routing packet.

BuyerPatient access, care navigation, discharge, and population health leaders
AgentScheduling Agent
Proof routes3
Exclusions4
Recommended pilot60-Day Governed Automation Pilot

Synthetic scenario

A deterministic synthetic access packet is organized into routing rationale, missing evidence, escalation signals, reviewer ownership, and blocked unsafe actions.

Run CarePath workflow demo
01Inspect the synthetic workflow objective and execution steps.
02Review routing rationale, missing evidence, and human-review requirements.
03Inspect the deterministic result fixture and Watchtower trace.
04Confirm patient outreach and live routing remain blocked.

Inspectable proof

Workflow, result, governance, and quality evidence remain one click away.

proof route

Workflow result

Deterministic output signals, review state, blocked actions, and Watchtower trace.

Inspect Workflow result

Commercial path

Recommended next step: 60-Day Governed Automation Pilot

Synthetic Pilot Evaluation

$125k-$350k for 45-90 days after sponsor and workflow owner are confirmed.

Access, care navigation, discharge, population health, and throughput leaders.

No autonomous outreach, diagnosis, treatment, emergency routing, PHI, or live workflow execution.
  • This is not emergency triage or patient outreach.
  • Pilot value is measured against routing friction, missing evidence, escalation clarity, and reviewer ownership.
  • Live patient routing waits for clinical authority and customer production approval.
Open recommended pilotStart no-PHI intake
Outcome 01

Structured access workqueue

Access bottlenecks surfaced

Outcome 02

Routing and escalation rationale

Manual review time targeted for reduction

Outcome 03

Reviewer ownership

Escalation reasons made inspectable

Outcome 04

Blocked patient-facing actions

Trust trace retained

Governance boundary

Human-reviewed synthetic evaluation only.

  • Human review is required before any external action.
  • Synthetic fixtures only.
  • Every blocked action remains visible in the result packet.
01No live patient routing
02No emergency triage replacement
03No autonomous outreach
04No diagnosis or treatment recommendation
BriefDownload demo brief

Share the buyer, proof path, outcomes, governance boundaries, and exclusions.

RunRun CarePath workflow demo

Inspect the current executable synthetic product surface.

PilotCompare pilot programs

Choose a structured engagement with outcomes, inputs, gates, and exclusions.

AcceleratorMap price and pilot path

Use market-aligned packaging before custom buyer work expands.

RequestRequest this evaluation

Start a governed buyer intake without submitting PHI.